Because GLP-1 medications are known to slow down the digestive process, some researchers hypothesize that they could theoretically increase the risk of these blockages in a very small number of patients
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: A randomized, double-blind, placebo-controlled, dose-finding phase 2 trial
It promotes fat storage, particularly in the abdominal area, and hinders the body's ability to use stored fat for energy
What You Need to Know Introduction It happens to the best of us
The product is intended exclusively for scientific investigation and should remain within controlled research environments at all times
If your hair loss persists, its a good idea to consult with your healthcare provider for further guidance